TRIBUN HEALTH RELEASES A NEW VERSION OF THE NEXT-GENERATION TELEPATHOLOGY SOLUTION FOR REMOTE CASE REVIEW.
AFTER TWO YEARS OF COMPLETE REDESIGN, TRIBUN HEALTH IS PROUD TO ANNOUNCE THE RELEASE OF TELESLIDE P...
Tribun Health Appoints Ludovic d’Apréa as Chief Customer Officer and Strengthens Its C-Level Global Team
PARIS, May 25, 2022 (Newswire.com) Tribun Health today announced the appointment of Ludovic d’...
Paige Announces Collaboration with Janssen to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by J...
Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis
Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe...
Proscia Introduces AI-Powered Quality Control to Accelerate Data-Driven Drug Development
Proscia®, a leader in digital and computational pathology solutions, has introduced an automated qua...
Paige AI Solution for Prostate Cancer Biomarker Detection Receives CE-IVD and UKCA Marks
First European regulatory clearance for Paige’s digital biomarker capabilities May 12, 2022 10:05 AM...
Tribun Health Is Entering The Pharmaceutical And Drug Development Market To Meet The Challenges Of Precision Medicine
Tribvn Healthcare) is pleased to announce the company’s expansion into the pharmaceutical market wit...
Paige Announces Expansion of Scientific Advisory Board
Paige, a global leader in AI applications in pathology, today announced several additions to its Sci...